Liver integrity and the risk of Alzheimer's disease and related dementias.
Yifei LuJames Russell PikeRon C HoogeveenKeenan A WalkerLaura M RaffieldElizabeth SelvinChristy L AveryStephanie M EngelMichelle M MielkeTanya GarciaPriya PaltaPublished in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2023)
Our findings highlight dementia burden in high-prevalent NAFLD and the important feature of late-life aminotransaminase as a surrogate biomarker linking liver hypometabolism to dementia. Highlights Although evidence of liver involvement in dementia development has been documented in animal studies, the evidence in humans is limited. Midlife NAFLD raised dementia risk proportionate to severity. Late-life NAFLD was not associated with a high risk of dementia. Low alanine aminotransferase was associated with an elevated dementia risk, especially when measured in late life.